1.The transfer system of trauma patient to emergency center.
Ok Jun KIM ; Ok Kyung CHOI ; Hong Du GOO ; Seung Whan KIM ; Seung Ho KIM
Journal of the Korean Society of Emergency Medicine 1993;4(1):112-121
No abstract available.
Emergencies*
;
Humans
2.Autoimmune Hemolytic Anemia after Intravenous Immunoglobulin Therapy in a Child with Kawasaki Disease
Joung Whan MOON ; Seung Hyun LEE ; Yeon Kyun OH ; Du Young CHOI ; Seung Taek YU
Clinical Pediatric Hematology-Oncology 2016;23(2):162-166
Kawasaki disease (KD) can cause acquired heart disease and systemic vasculitis in children. It is treated with intravenous immunoglobulin (IVIG). A significant complication is development of coronary artery lesions such as dilatations or aneurysms. However, uncommon complications can occur, like autoimmune hemolytic anemia when IVIG is used. We present a case of autoimmune hemolytic anemia associated with KD. Dilatation of right coronary artery was found at echocardiography and he was treated twice with IVIG (2 g/kg) with interval of 48 hours. Laboratory finding showed hemoglobin 7.1 g/dL, hematocrit 20.8%, corrected reticulocyte 5.86%, total bilirubin 0.29 mg/dL, lactate dehydrogenase 425 IU/L, and haptoglobin 5 mg/dL. Normocytic, normochromic anemia with anisopoikilocytosis was found on peripheral blood smear, and direct antiglobulin test was positive. The patient was started on oral prednisolone for 3 weeks, with which all symptoms resolved. We report this rare case, prompting consideration of IVIG associated complications when treating KD.
Anemia
;
Anemia, Hemolytic, Autoimmune
;
Aneurysm
;
Bilirubin
;
Child
;
Coombs Test
;
Coronary Vessels
;
Dilatation
;
Echocardiography
;
Haptoglobins
;
Heart Diseases
;
Hematocrit
;
Humans
;
Immunization, Passive
;
Immunoglobulins
;
Immunoglobulins, Intravenous
;
L-Lactate Dehydrogenase
;
Mucocutaneous Lymph Node Syndrome
;
Prednisolone
;
Reticulocytes
;
Systemic Vasculitis
3.Priapism Associated with the Discontinuation of Oral Wafarin.
Mi Ho SONG ; Seung Whan DU ; Won Jae YANG ; Yun Seob SONG
Korean Journal of Andrology 2010;28(2):141-143
Priapism attributable to an anticoagulant drug has rarely been reported. Although the pathophysiology of this type of priapism is not well understood, most investigators contend that thromboembolic phenomena play either a causative or supportive role. We describe a case of priapism associated with the discontinuation of oral warfarin.
Heparin
;
Humans
;
Priapism
;
Research Personnel
;
Warfarin
4.A Case of Huge Empyema Caused by Pulmonary Actinomycosis.
Duck Ryung KIM ; Yoon Hee CHOI ; Seung Whan LEE ; Jong Sin LEE ; Min Jae KIM ; Seung Sook LEE ; Du Hwan CHOE ; Cheol Hyeon KIM ; Jae Cheol LEE
Tuberculosis and Respiratory Diseases 2004;57(6):579-583
Actinomycosis is an indolent infectious disease characterized by pyogenic response and necrosis, followed by intense fibrosis. The main forms of human actinomycosis are cervicofacial, pulmonary, and abdominopelvic type. Pulmonary actinomycosis accounts for 15% to 20% of total cases and unfortunately, clinical manifestations and radiologic findings are nonspecific. Small pleural effusion or empyema may develop in advanced disease but massive empyema is infrequent and rarely reported. We report a case of huge empyema caused by pulmonary actinomycosis in a 55 year-old man, presented with one-month history of productive cough and fever. The CT scan revealed a huge cavity with air-fluid level occupying the left hemithorax. Empyema caused by actinomycosis was confirmed microscopically by demonstration of sulfur granules in empyema sac through thracotomy. Decortication and surgical resection of empyema sac and destructed lung was accomplished and followed by intravenous infusion of penicillin G.
Actinomycosis*
;
Communicable Diseases
;
Cough
;
Empyema*
;
Fever
;
Fibrosis
;
Humans
;
Infusions, Intravenous
;
Lung
;
Middle Aged
;
Necrosis
;
Penicillin G
;
Pleural Effusion
;
Sulfur
;
Tomography, X-Ray Computed
5.Early and late clinical outcomes after primary stenting of the unprotected left main coronary artery stenosis in the setting of acute myocardial infarction.
Myung Zoon YI ; Seung Whan LEE ; Sae Hwan LEE ; Chang Bum PARK ; Sung Du KIM ; Song Yi HAN ; Young Hak KIM ; Cheol Whan LEE ; Myeong Ki HONG ; Jae Joong KIM ; Seong Wook PARK ; Seung Jung PARK
Korean Journal of Medicine 2004;67(3):249-254
BACKGROUND: Acute left main coronary artery occlusion is a dramatic condition with very high mortality. The study was aimed to evaluate the effect of primary stenting in patients with left main coronary artery disease in the setting of acute myocardial infarction. METHODS: Between June 1997 and April 2002, primary stenting for left main coronary artery disease was performed in eighteen patients with acute myocardial infarction. We evaluated clinical outcomes and prognostic determinants in this clinical setting. RESULTS: Mean ages of patients were 59 +/- 12 years. Fourteen patients had cardiogenic shock on admission. Angiographic success (TIMI flow >or= 2 and diameter stenosis < 30% after stenting) was achieved in 17 patients (94%). In-hospital death occurred in 8 patients (44%). Two patients (11%) received emergent bypass surgery because of hemodynamic instability after primary stenting. On univariate analysis, good pre-intervention TIMI flow (grade >or= 2) was identified as a good prognostic determinant of in-hospital survival. During mean follow-up of 39 +/- 22 months, there was no late death and 1 patient received bypass surgery. Probability of freedom from death at 3-year was 56 +/- 12%. CONCLUSION: Primary stenting is a valuable therapeutic strategy for left main coronary disease in the setting of acute myocardial infarction, and it might save the life especially in patients with good pre-intervention TIMI flow (grade >or= 2). Long-term clinical outcome of patients surviving to hospital discharge is favorable.
Constriction, Pathologic
;
Coronary Artery Disease
;
Coronary Disease
;
Coronary Stenosis*
;
Coronary Vessels*
;
Follow-Up Studies
;
Freedom
;
Hemodynamics
;
Humans
;
Mortality
;
Myocardial Infarction*
;
Shock, Cardiogenic
;
Stents*
6.Gefitinib-Related Interstitial Pneumonia.
Ho Jin LEE ; Seung Bum NAM ; Jae Wook JUNG ; Im Il NA ; Cheol Hyeon KIM ; Baek Yeol RYOO ; Du Whan CHOE ; Jin Hyung KANG ; Jae Cheol LEE
Tuberculosis and Respiratory Diseases 2007;62(2):134-139
Gefitinib is a novel drug used to treat advanced non-small cell lung cancer. However, drug-related interstitial pneumonia is a major life-threatening side effect, which has a worldwide prevalence of 0.3-0.4%. In Japan, the prevalence is high as 3-4% but the actual frequency in Korea has not been officially assessed. We report two cases of gefitinib-induced interstitial lung disease during the treatment of non-small cell lung cancer. High-resolution computerized tomography (HRCT) of one case showed nonspecific ground glass opacity and the chest x-ray of another case showed diffuse bilateral ground glass opacity. The former patient showed a rapid good response to corticosteroid treatment whereas the latter died despite receiving aggressive treatment with high dose corticosteroid and empirical antibiotics.
Anti-Bacterial Agents
;
Carcinoma, Non-Small-Cell Lung
;
Glass
;
Humans
;
Japan
;
Korea
;
Lung Diseases, Interstitial*
;
Prevalence
;
Thorax